{
    "nctId": "NCT06358625",
    "briefTitle": "Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer",
    "officialTitle": "Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "HER2-positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Transcriptomic profile change of HER2+ primary breast tumours before any treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years old\n* be a female patient\n* Patients with histologically proven HER2-positive invasive breast cancer (IHC 3+ or 2+ with positive SISH),\n* Neoadjuvant chemotherapy and intra-tumour clips indicated at the multidisciplinary consultation meeting (RCP).\n* Signed Informed Consent Form\n\nExclusion Criteria:\n\n* pregnant or breast-feeding women\n* Have had a haematoma requiring level II analgesics at the time of the diagnostic biopsy.\n* Known coagulation disorders\n* Individual deprived of liberty or placed under the authority of a tutor, or a currator\n* Not be affiliated to a social security regimen",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}